Another reality check: the direct costs of providing post-exposure prophylaxis in a population-based programme.
Braitstein
P
P
Chan
K
K
Beardsell
A
A
McLeod
A
A
Montaner
J S
JS
O'Shaughnessy
M V
MV
Hogg
R S
RS
D019380:Anti-HIV Agents / Q000191:economics* / Q000627:therapeutic use; D018890:Chemoprevention / Q000191:economics; D016527:Drug Costs / Q000706:statistics & numerical data*; D011307:Drug Prescriptions / Q000191:economics; D015658:HIV Infections / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D010349:Patient Compliance; D011795:Surveys and Questionnaires
D019380:Anti-HIV Agents